Discover trends, market shifts, and competitive outlooks for the cancer tumor profiling industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Cancer Tumor Profiling Market Through 2034?

The market size for cancer tumor profiling has experienced swift expansion in the past few years. The market valuation is projected to increase from $13 billion in 2024 to $14.99 billion in 2025, marking a compound annual growth rate (CAGR) of 15.3%. This growth during the historical period is credited to factors such as the escalating incidences of cancer, advancements in precision medicine initiatives and research collaborations, enhancements in cancer diagnostics and early detection techniques, the accessibility of numerous targeted therapy options, and favorable regulatory structures for cancer profiling tests.

Anticipations are high for a substantial proliferation in the size of the cancer tumor profiling market over the upcoming years, with predictions suggesting it will reach a value of $25.33 billion in 2029, equating to a compound annual growth rate (CAGR) of 14.0%. This projected expansion during the forecast period is linked to the widespread use of immunotherapy and immunoprofiling in cancer treatment, advancements in non-invasive tumor profiling and liquid biopsy methods, the incorporation of single-cell sequencing for in-depth tumor analysis, increased emphasis on cancer screening and early detection programs, and the heightened demand for profiling of rare and orphan cancer subtypes. The forecast period is also set to see key trends such as the standardization of tumor profiling in everyday clinical practices, advancements in multi-omics approaches, inclusion of artificial intelligence (AI) and machine learning in data interpretation, developments in precision medicine and targeted therapies, as well as improvements in genomics and next-generation sequencing (NGS) technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What Are the Core Growth Drivers Propelling the Cancer Tumor Profiling Market Forward?

The escalating occurrences of cancer worldwide are predicted to drive the expansion of the cancer and tumor profiling market. Cancer, a condition marked by uncontrolled cell growth and spreading across the body, elevates the need for cancer tumor profiling, which allows physicians to assess disease severity. For example, the American Cancer Society, a professional organization based in the US, documented 2 million fresh cancer diagnoses in 2024, a rise from 1.9 million new instances in 2023. Thus, the growing prevalence of cancer globally fuels the development of the cancer and tumor profiling market.

What Segment Types Define the Cancer Tumor Profiling Market Structure?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6053&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cancer Tumor Profiling Market?

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Emerging Trends that Are Influencing theCancer Tumor Profiling Industry Evolution?

A rising trend in the cancer and tumor profiling market has been identified as extensive research and development activities. Prominent businesses in this sector, such as the Germany-based QIAGEN N.V., are investing heavily in these areas to satisfy client needs and cement their standing in the market. An example of this is their recent introduction of the therascreen PIK3CA RGQ PCR Kit in Europe, having been granted the necessary Conformitè Europëenne (CE) mark. The Kit is aimed at detecting breast cancer patients with PIK3CA mutations, providing a diagnostic assay for the detection of this mutation in the PIK3CA gene. This assay tests for DNA in plasma samples or FFPE tissue, a first in its kind.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

What Is the Definition of the Cancer Tumor Profiling Market?

Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model